Olivier Francois Roussy Newton

Secfi is one of the leading providers of equity planning, stock option financing, and wealth management for tech employees and founders. Offering a digital platform for equity planning, 1:1 financial advice, ongoing investment management, and tools like equity planners and tax calculators, Secfi helps clients maximize the value of their equity compensation and own a stake in the company they helped build. With liquidity solutions such as secondary sales and non-recourse financing, Secfi serves employees from over 90% of U.S. unicorns, assisting more than 46,000 individuals and representing $80 billion in equity value. Data current as of October 2024.

ZY4 is a fast, reliable form of end-to-end encryption with authentication that works over any distance on any data network. ZY4 encryption keys are designed to operate in a unique space of computational complexity with irreversible computational problems which are non-physical, combining information theoretic security and factorial space problems requiring either or both infinite memory or time for quantum computers (or conventional computers) to solve.

BTQ is a global quantum technology company focused on securing mission critical networks.

Established in 2019, Valour is a wholly owned subsidiary of DeFi Technologies Inc.(NEO: DEFI) (GR: MB9) (OTC: DEFTF) - https://www.linkedin.com/company/defitechglobal // Valour Inc. issues exchange traded products (ETPs) that enable retail and institutional investors to access digital assets like Bitcoin in a simple and secure way via their traditional bank account. For more information or to subscribe to receive company updates and financial information, visit https://valour.com

Exponential Genomics (Xenomics) is building next-generation life science companies focused on combating the world’s greatest challenges—feeding, fueling, and healing humanity. Built by a team of scientists trained at Harvard and MIT, our core technology is a novel gene-editing technique capable of performing over 400 years of CRISPR in 8 weeks. Our Xenoarray technology is well-positioned to revolutionize gene editing techniques by enabling gene knock-ins of up to 8,000 base pairs or 8 unique genes. We anticipate obtaining at least 3,000 unique cell lines from each experiment, which could radically streamline the process of integrating parallel workflows in bioengineering. Exponential’s current commercialization projects include streamlining the manufacturing of biopharmaceuticals, vaccines, human breastmilk, cell therapies, cultured meats & dairy, water desalination, carbon recycling, cannabinoids, psychedelics, food flavors, and perfume scents.

HIVE Digital Technologies is a leading data center owner and operator. The company’s infrastructure includes over 100 megawatts of Bitcoin mining and fast-growing GPU cloud business powered by its industrial-grade NVIDIA GPUs. HIVE trades on the Nasdaq and TSX Venture Exchanges, under the ticker symbol HIVE, and on the Frankfurt Stock Exchange under the ticker YO0.F. The company’s facilities are strategically located near clean, low-cost energy sources such as hydroelectric and geothermal plants. Learn more at: www.hivedigitaltechnologies.com